Next Article in Journal
Epigenetics Meets Radiation Biology as a New Approach in Cancer Treatment
Next Article in Special Issue
Early Lung Cancer Diagnosis by Biosensors
Previous Article in Journal
Effect of a Static Magnetic Fields and Fluoride Ions on the Antioxidant Defense System of Mice Fibroblasts
Previous Article in Special Issue
Clinical Advances in Molecular Biomarkers for Cancer Diagnosis and Therapy
Open AccessReview

DNA Methylation and Cancer Diagnosis

Cancer Research Center of Toulouse Inserm UMR 1037, 31432 Toulouse cedex 4, France
University de Toulouse III-Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse cedex 9, France
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2013, 14(7), 15029-15058;
Received: 10 May 2013 / Revised: 28 June 2013 / Accepted: 4 July 2013 / Published: 18 July 2013
(This article belongs to the Special Issue Advances in Cancer Diagnosis)
DNA methylation is a major epigenetic modification that is strongly involved in the physiological control of genome expression. DNA methylation patterns are largely modified in cancer cells and can therefore be used to distinguish cancer cells from normal tissues. This review describes the main technologies available for the detection and the discovery of aberrantly methylated DNA patterns. It also presents the different sources of biological samples suitable for DNA methylation studies. We discuss the interest and perspectives on the use of DNA methylation measurements for cancer diagnosis through examples of methylated genes commonly documented in the literature. The discussion leads to our consideration for why DNA methylation is not commonly used in clinical practice through an examination of the main requirements that constitute a reliable biomarker. Finally, we describe the main DNA methylation inhibitors currently used in clinical trials and those that exhibit promising results. View Full-Text
Keywords: DNA methylation; biomarkers; cancer diagnosis; DNA methylation inhibitors; clinical trials DNA methylation; biomarkers; cancer diagnosis; DNA methylation inhibitors; clinical trials
MDPI and ACS Style

Delpu, Y.; Cordelier, P.; Cho, W.C.; Torrisani, J. DNA Methylation and Cancer Diagnosis. Int. J. Mol. Sci. 2013, 14, 15029-15058.

AMA Style

Delpu Y, Cordelier P, Cho WC, Torrisani J. DNA Methylation and Cancer Diagnosis. International Journal of Molecular Sciences. 2013; 14(7):15029-15058.

Chicago/Turabian Style

Delpu, Yannick; Cordelier, Pierre; Cho, William C.; Torrisani, Jérôme. 2013. "DNA Methylation and Cancer Diagnosis" Int. J. Mol. Sci. 14, no. 7: 15029-15058.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop